1 North Wealth Services LLC boosted its holdings in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 0.9% during the first quarter, Holdings Channel reports. The fund owned 15,784 shares of the financial services provider’s stock after acquiring an additional 139 shares during the period. iShares Nasdaq Biotechnology ETF accounts for 1.2% of 1 North Wealth Services LLC’s investment portfolio, making the stock its 26th largest holding. 1 North Wealth Services LLC’s holdings in iShares Nasdaq Biotechnology ETF were worth $1,765,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. Stone House Investment Management LLC purchased a new position in shares of iShares Nasdaq Biotechnology ETF during the 1st quarter worth about $27,000. Trustcore Financial Services LLC purchased a new position in shares of iShares Nasdaq Biotechnology ETF during the 1st quarter worth about $34,000. Parkside Financial Bank & Trust purchased a new position in shares of iShares Nasdaq Biotechnology ETF during the 4th quarter worth about $29,000. Sontag Advisory LLC purchased a new position in shares of iShares Nasdaq Biotechnology ETF during the 4th quarter worth about $32,000. Finally, Destination Wealth Management purchased a new position in shares of iShares Nasdaq Biotechnology ETF during the 1st quarter worth about $42,000. 67.92% of the stock is currently owned by hedge funds and other institutional investors.

Shares of IBB stock opened at $102.32 on Tuesday. iShares Nasdaq Biotechnology ETF has a 1-year low of $89.01 and a 1-year high of $122.97.

TRADEMARK VIOLATION NOTICE: “1 North Wealth Services LLC Raises Position in iShares Nasdaq Biotechnology ETF (IBB)” was first reported by Watch List News and is the property of of Watch List News. If you are viewing this article on another domain, it was stolen and reposted in violation of U.S. and international trademark and copyright laws. The correct version of this article can be viewed at https://www.watchlistnews.com/1-north-wealth-services-llc-raises-position-in-ishares-nasdaq-biotechnology-etf-ibb/3017239.html.

iShares Nasdaq Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

See Also: Book Value Per Share – BVPS

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB).

Institutional Ownership by Quarter for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.